Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
株式のランク #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
株価
$1.51
最終同期: 2024-08-26
時価総額
$1.12M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Agile Therapeutics, Inc. (AGRX)

カテゴリー

Agile Therapeutics, Inc.(AGRX)の株式分割履歴
Agile Therapeutics, Inc.株(シンボル:AGRX)は合計で2回の株式分割を実施しました。
最新の株式分割はApr 11, 2023に行われました。
Apr 27, 2022より前に購入されたAGRX株は、現在0.0005AGRX株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2023-04-11 1:50 x0.02 x0.0005
2022-04-27 1:40 x0.025 x0.025
類似企業または競合他社の株式分割